A secondary prevention patient centred model for smoking cessation.
Not Applicable
Recruiting
- Conditions
- Smoking cessation in cardiovascular patients.Secondary prevention.Cardiovascular - Coronary heart diseaseCardiovascular - Other cardiovascular diseasesPublic Health - Health promotion/education
- Registration Number
- ACTRN12612000016831
- Lead Sponsor
- St Vincent’s Hospital Melbourne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
1. Primary diagnosis of one or more of the following: stable angina, atherosclerotic related events such as acute coronary syndrome, coronary artery bypass grafts, stroke, transient ischemic attack, or peripheral vascular disease.
2. Aged 18 and above
3. Telephone access
4. Current smoker
5. Fluent in English
Exclusion Criteria
1. Diagnosed with a terminal illness
2. Cognitive impairment that may impact upon ability to participate in the trial
3. Participant is housebound
4. Participation in other research trial that may interfere with the trial
5. Inability to give informed consent
6. Any other factor impacting upon ability to give informed consent or participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (O) The most favourable outcome after access to the evidence based smoking cessation program is smoking abstinence. Objective measures will be taken during the clinical visits using the Smokelyser in order to validate abstinence. Carbon monoxide level CO levels below 10ppm (parts per million) are considered reliable indicator of non-smoking. Questions during the contacts with the clinical nurses will provide additional subjective data on the quit-rate.[Visits are scheduled 2 weekly and run for 12 weeks with optional extension to 24 weeks (same schedule) if indicated.]
- Secondary Outcome Measures
Name Time Method